The genetic profiles of esophageal squamous cell carcinoma (ESCC) in Hebei, a northern province of China.

被引：0
|
作者：
Zuo, Jing
Jia, Yimeng
Wang, Yudong
Fan, Zhisong
Wang, Long
Su, Yu
Liu, Fengling
Jiang, Da
机构：
[1] Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15558
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Precision screening for esophageal squamous cell carcinoma in China
    Zhonghu He
    Yang Ke
    Chinese Journal of Cancer Research, 2020, 32 (06) : 673 - 682
  • [32] Altered miRNA Expression is Associated with Differentiation, Invasion, and Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) in Patients from Huaian, China
    Hai Long Fu
    De Ping Wu
    Xiu Fang Wang
    Jian Guo Wang
    Feng Jiao
    Lei Lei Song
    Hui Xie
    Xu Yang Wen
    Hu Sheng Shan
    Yun Xiang Du
    Ya Ping Zhao
    Cell Biochemistry and Biophysics, 2013, 67 : 657 - 668
  • [33] Expression of ATP7A in esophageal squamous cell carcinoma (ESCC) and its clinical significance
    Li, Zhuang-Hua
    Lu, Xuan
    Li, Shao-Wen
    Chen, Jing-Tang
    Jia, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3521 - 3525
  • [34] Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
    Wang, Yang
    Sheng, Shijie
    Zhang, Jianzhi
    Dzinic, Sijana
    Li, Shaolei
    Fang, Fang
    Wu, Nan
    Zheng, Qingfeng
    Yang, Yue
    PLOS ONE, 2013, 8 (05):
  • [35] COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID
    Liu, X.
    Li, P.
    Zhang, S. -T.
    You, H.
    Jia, J. -D.
    Yu, Z. -L.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (01): : 9 - 14
  • [36] A Meta-Analysis of HIF-1α and Esophageal Squamous Cell Carcinoma (ESCC) Risk
    Sun, Guogui
    Hu, Wanning
    Lu, Yifang
    Wang, Yadi
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (04) : 685 - 693
  • [37] Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)
    He, J.
    Zhao, L.
    Li, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1553 - S1553
  • [38] A phase II study of apatinib in patients with recurrent/metastatic esophageal squamous cell carcinoma (ESCC)
    Chu, L.
    Liang, F.
    Zhang, J.
    Deng, J.
    Chen, Y.
    Liu, Q.
    Ai, D.
    Zhu, Z.
    Zhao, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Aurora-A enhances malignant development of esophageal squamous cell carcinoma (ESCC) by phosphorylating β-catenin
    Jin, Shunqian
    Wang, Xiaoxia
    Tong, Tong
    Zhang, Dongdong
    Shi, Ji
    Chen, Jie
    Zhan, Qimin
    MOLECULAR ONCOLOGY, 2015, 9 (01): : 249 - 259
  • [40] COMBINED THERAPIES IN ESOPHAGEAL SQUAMOUS-CELL CANCER (ESCC)
    FRANKLIN, R
    STEIGER, Z
    VAISHAMPAYAN, G
    HOSCHNER, J
    VAITKEVICIUS, VK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 418 - 418
12345